WhitTier Trust Company’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-56
Closed -$1.76K 1387
2025
Q2
$1.76K Hold
56
﹤0.01% 1323
2025
Q1
$1.66K Hold
56
﹤0.01% 1301
2024
Q4
$1.65K Buy
56
+1
+2% +$32 ﹤0.01% 1249
2024
Q3
$1.71K Hold
55
﹤0.01% 1235
2024
Q2
$1.86K Hold
55
﹤0.01% 1179
2024
Q1
$3.58K Sell
55
-3
-5% -$206 ﹤0.01% 1075
2023
Q4
$3.96K Buy
58
+11
+23% +$572 ﹤0.01% 1066
2023
Q3
$2.44K Buy
47
+13
+38% +$769 ﹤0.01% 1062
2023
Q2
$2.04K Buy
+34
New +$1.94K ﹤0.01% 1103

Other funds holding IMCR

WhitTier Trust Company's IMCR Position: Q3 2025 in Review

WhitTier Trust Company sold out of Immunocore (IMCR) in Q3 2025, closing a stake of 56 shares — an estimated $1.76K sold.

WhitTier Trust Company first reported a position in IMCR in Q2 2023 and held it in 9 quarters. The position peaked at $3.96K in Q4 2023. 132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • WhitTier Trust Company reported no remaining Immunocore position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 56 Immunocore shares in Q3 2025, an estimated $1.76K.
  • WhitTier Trust Company first reported a position in Immunocore in Q2 2023 and held it in 9 quarters.
  • WhitTier Trust Company's Immunocore position peaked at $3.96K in Q4 2023.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.